-
1
-
-
70350513270
-
Regulation of tissue homeostasis by NF-kappaB signalling: Implications for inflammatory diseases
-
Pasparakis M. Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nat Rev Immunol. 2009;9:778-88.
-
(2009)
Nat Rev Immunol
, vol.9
, pp. 778-788
-
-
Pasparakis, M.1
-
2
-
-
35648941579
-
Targeting NOX INOS and COX-2 in inflammatory cells: Chemoprevention using food phytochemicals
-
Murakami A, Ohigashi H. Targeting NOX INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. Int J Cancer. 2007;121:2357-63.
-
(2007)
Int J Cancer
, vol.121
, pp. 2357-2363
-
-
Murakami, A.1
Ohigashi, H.2
-
3
-
-
4444263810
-
Molecular therapeutic targets in inflammation: Cyclooxygenase and NF-kappaB
-
Krakauer T. Molecular therapeutic targets in inflammation: cyclooxygenase and NF-kappaB. Curr Drug Targets Inflamm Allergy. 2004;3:317-24.
-
(2004)
Curr Drug Targets Inflamm Allergy
, vol.3
, pp. 317-324
-
-
Krakauer, T.1
-
4
-
-
78649526394
-
Sterile inflammation: Sensing and reacting to damage
-
Chen GY, Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010;10:826-37.
-
(2010)
Nat Rev Immunol
, vol.10
, pp. 826-837
-
-
Chen, G.Y.1
Nuñez, G.2
-
5
-
-
0036618421
-
Role of nuclear factor kappaB in synovial inflammation
-
Müller-Ladner U, Gay RE, Gay S. Role of nuclear factor kappaB in synovial inflammation. Curr Rheumatol Rep. 2002;4:201-7.
-
(2002)
Curr Rheumatol Rep
, vol.4
, pp. 201-207
-
-
Müller-Ladner, U.1
Gay, R.E.2
Gay, S.3
-
6
-
-
77950825019
-
Molecular pathways and targets in cancer-related inflammation
-
Mantovani A, Garlanda C, Allavena P. Molecular pathways and targets in cancer-related inflammation. Ann Med. 2010;42: 161-70.
-
(2010)
Ann Med.
, vol.42
, pp. 161-170
-
-
Mantovani, A.1
Garlanda, C.2
Allavena, P.3
-
7
-
-
78650878363
-
NF-?B, inflammation, and metabolic disease
-
Baker RG, Hayden MS, Ghosh S. NF-?B, inflammation, and metabolic disease. Cell Metab. 2011;13:11-22.
-
(2011)
Cell Metab
, vol.13
, pp. 11-22
-
-
Baker, R.G.1
Hayden, M.S.2
Ghosh, S.3
-
8
-
-
34249997787
-
Tolllike receptor 4 siRNA attenuates LPS-induced secretion of inflammatory cytokines and chemokines by macrophages
-
Xu Z, Huang CX, Li Y, Wang PZ, Ren GL, Chen CS, Shang FJ, Zhang Y, Liu QQ, Jia ZS, Nie QH, Sun YT, Bai XF. Tolllike receptor 4 siRNA attenuates LPS-induced secretion of inflammatory cytokines and chemokines by macrophages. J Infect. 2007;55:e1-e9.
-
(2007)
J Infect.
, vol.55
-
-
Xu, Z.1
Huang, C.X.2
Li, Y.3
Wang, P.Z.4
Ren, G.L.5
Chen, C.S.6
Shang, F.J.7
Zhang, Y.8
Liu, Q.Q.9
Jia, Z.S.10
Nie, Q.H.11
Sun, Y.T.12
Bai, X.F.13
-
9
-
-
0242552753
-
Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: Roles of the receptor complex
-
Fujihara M, Muroi M, Tanamoto K, Suzuki T, Azuma H, Ikeda H. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol Ther. 2003;100:171-94.
-
(2003)
Pharmacol Ther.
, vol.100
, pp. 171-194
-
-
Fujihara, M.1
Muroi, M.2
Tanamoto, K.3
Suzuki, T.4
Azuma, H.5
Ikeda, H.6
-
10
-
-
33646028804
-
Molecular targets of dietary agents for prevention and therapy of cancer
-
Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 2006;71:1397-421.
-
(2006)
Biochem Pharmacol
, vol.71
, pp. 1397-1421
-
-
Aggarwal, B.B.1
Shishodia, S.2
-
11
-
-
9744222928
-
Potential synergy of phytochemicals in cancer prevention: Mechanism of action
-
Liu RH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr. 2004;134(Suppl):S3479-85.
-
(2004)
J Nutr.
, vol.134
, Issue.SUPPL.
-
-
Liu, R.H.1
-
12
-
-
48349091804
-
Dietary management of the metabolic syndrome beyond macronutrients
-
Minich DM, Bland JS. Dietary management of the metabolic syndrome beyond macronutrients. Nutr Rev. 2008;66:429-44.
-
(2008)
Nutr Rev.
, vol.66
, pp. 429-444
-
-
Minich, D.M.1
Bland, J.S.2
-
13
-
-
0036332286
-
Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China
-
Xiao Z, Hao Y, Liu B, Qian L. Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China. Leuk Lymphoma. 2002;43:1763-8.
-
(2002)
Leuk Lymphoma
, vol.43
, pp. 1763-1768
-
-
Xiao, Z.1
Hao, Y.2
Liu, B.3
Qian, L.4
-
14
-
-
33745594039
-
Indirubin-30-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent upregulation of survivin in transitional cell cancer
-
Perabo FG, Frössler C, Landwehrs G, Schmidt DH, von Rücker A, Wirger A, Müller SC. Indirubin-30-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent upregulation of survivin in transitional cell cancer. Anticancer Res. 2006;26:2129-35.
-
(2006)
Anticancer Res
, vol.26
, pp. 2129-2135
-
-
Perabo, F.G.1
Frössler, C.2
Landwehrs, G.3
Schmidt, D.H.4
Von, R.A.5
Wirger, A.6
Müller, S.C.7
-
15
-
-
20944435625
-
Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells
-
Nam S, Buettner R, Turkson J, Kim D, Cheng JQ, Muehlbeyer S, Hippe F, Vatter S, Merz KH, Eisenbrand G, Jove R. Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells. Proc Natl Acad Sci USA. 2005;102:5998-6003.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 5998-6003
-
-
Nam, S.1
Buettner, R.2
Turkson, J.3
Kim, D.4
Cheng, J.Q.5
Muehlbeyer, S.6
Hippe, F.7
Vatter, S.8
Merz, K.H.9
Eisenbrand, G.10
Jove, R.11
-
16
-
-
33747698455
-
Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-kB signaling pathway
-
Sethi G, Ahn KS, Sandur SK, Lin X, Chaturvedi MM, Aggarwal BB. Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-kB signaling pathway. J Biol Chem. 2006;281:23425-35.
-
(2006)
J Biol Chem.
, vol.281
, pp. 23425-23435
-
-
Sethi, G.1
Ahn, K.S.2
Sandur, S.K.3
Lin, X.4
Chaturvedi, M.M.5
Aggarwal, B.B.6
-
17
-
-
34249700741
-
Challenges and opportunities in drug discovery from plant
-
Jachak SM, Saklani A. Challenges and opportunities in drug discovery from plant. Curr Sci. 2007;92:1251-7.
-
(2007)
Curr Sci
, vol.92
, pp. 1251-1257
-
-
Jachak, S.M.1
Saklani, A.2
-
18
-
-
33846279781
-
Antitumor activity of novel indirubin derivatives in rat tumor model
-
Kim SA, Kim YC, Kim SW, Lee SH, Min JJ, Ahn SG, Yoon JH. Antitumor activity of novel indirubin derivatives in rat tumor model. Clin Cancer Res. 2007;13:253-9.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 253-259
-
-
Kim, S.A.1
Kim, Y.C.2
Kim, S.W.3
Lee, S.H.4
Min, J.J.5
Ahn, S.G.6
Yoon, J.H.7
-
19
-
-
8644224855
-
Molecular mechanisms of indirubin and its derivatives: Novel anticancer molecules with their origin in traditional Chinese phytomedicine
-
Eisenbrand G, Hippe F, Jakobs S, Muehlbeyer S. Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine. J Cancer Res Clin Oncol. 2004;130:627-35.
-
(2004)
J Cancer Res Clin Oncol.
, vol.130
, pp. 627-635
-
-
Eisenbrand, G.1
Hippe, F.2
Jakobs, S.3
Muehlbeyer, S.4
-
20
-
-
45449102255
-
7-Bromoindirubin-30-oxime uncovers a serine proteasemediated paradigm of necrotic cell death
-
Ribas J, Yuste VJ, Garrofé-Ochoa X, Meijer L, Esquerda JE, Boix J. 7-Bromoindirubin-30-oxime uncovers a serine proteasemediated paradigm of necrotic cell death. Biochem Pharmacol. 2008;76:39-52.
-
(2008)
Biochem Pharmacol
, vol.76
, pp. 39-52
-
-
Ribas, J.1
Yuste, V.J.2
Garrofé-Ochoa, X.3
Meijer, L.4
Esquerda, J.E.5
Boix, J.6
-
21
-
-
79953687398
-
Indirubin-30-monoxime, a derivative of a chinese antileukemia medicine, inhibits angiogenesis
-
Kim JK, Shin EK, Kang YH, Park JH. Indirubin-30-monoxime, a derivative of a chinese antileukemia medicine, inhibits angiogenesis. J Cell Biochem. 2011;112:1384-91.
-
(2011)
J Cell Biochem
, vol.112
, pp. 1384-1391
-
-
Kim, J.K.1
Shin, E.K.2
Kang, Y.H.3
Park, J.H.4
-
22
-
-
69449088578
-
MAPK signaling pathways in the regulation of hematopoiesis
-
Geest CR, Coffer PJ. MAPK signaling pathways in the regulation of hematopoiesis. J Leukoc Biol. 2009;86:237-50.
-
(2009)
J Leukoc Biol.
, vol.86
, pp. 237-250
-
-
Geest, C.R.1
Coffer, P.J.2
-
23
-
-
34547226194
-
Regulation of MAPKs by growth factors and receptor tyrosine kinases
-
Katz M, Amit I, Yarden Y. Regulation of MAPKs by growth factors and receptor tyrosine kinases. Biochim Biophys Acta. 2007;1773:1161-76.
-
(2007)
Biochim Biophys Acta
, vol.1773
, pp. 1161-1176
-
-
Katz, M.1
Amit, I.2
Yarden, Y.3
-
24
-
-
29144511607
-
MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits
-
Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta. 2005;1754:253-62.
-
(2005)
Biochim Biophys Acta
, vol.1754
, pp. 253-262
-
-
Kaminska, B.1
-
25
-
-
0031840980
-
Role of transcription factors in inflammatory lung diseases
-
Rahman I, MacNee W. Role of transcription factors in inflammatory lung diseases. Thorax. 1988;53:601-12.
-
(1988)
Thorax
, vol.53
, pp. 601-612
-
-
Rahman, I.1
Macnee, W.2
-
26
-
-
24944568241
-
6-(Methylsulfinyl)hexyl isothiocyanate suppresses inducible nitric oxide synthase expression through the inhibition of Janus kinase 2-mediated JNK pathway in lipopolysaccharide- activated murine macrophages
-
Uto T, Fujii M, Hou DX. 6-(Methylsulfinyl)hexyl isothiocyanate suppresses inducible nitric oxide synthase expression through the inhibition of Janus kinase 2-mediated JNK pathway in lipopolysaccharide- activated murine macrophages. Biochem Pharmacol. 2005;70:1211-21.
-
(2005)
Biochem Pharmacol
, vol.70
, pp. 1211-1221
-
-
Uto, T.1
Fujii, M.2
Hou, D.X.3
|